(RTTNews) - Vor Biopharma (VOR), a clinical-stage cell and genome engineering company, announced that its VOR33 was granted Fast Track designation by the U.S. Food and Drug Administration. VOR33 is ...
Dr. Khan brings decades of global medical affairs, commercial, and scientific leadership across multiple therapeutic areas ...
CAMBRIDGE, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback